Law Offices of Howard G. Smith announces an investigation on behalf of Teladoc Health, Inc. investors (Teladoc or the Company) (NYSE: TDOC) concerning the Company and its officers possible violations of federal securities laws.
On December 5, 2018, the Southern Investigative Research Foundation (SIRF) published an article alleging that Teladocs Chief Financial Officer provided trading advice to a junior employee regarding Teladoc securities, telling her when he thought there were good opportunities to sell some shares. On this news, Teladocs share price fell more than 10%, closing at $55.81 per share on December 6, 2018, thereby injuring investors.
If you purchased Teladoc securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847, toll-free at (888) 638-4847, or by email to [email protected], or visit our website at www.howardsmithlaw.com.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
WANT TO BUILD A FINANCIAL EMPIRE?
Subscribe to the Global Banking & Finance Review Newsletter for FREE Get Access to Exclusive Reports to Save Time & Money
By using this form you agree with the storage and handling of your data by this website. We Will Not Spam, Rent, or Sell Your Information.